This HubSpot Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday
Avi Kapoor 5 months ago
NewsDowngradesPre-Market OutlookMarketsAnalyst RatingsTrading Ideas
Wall Street analysts changed outlook on top names. Check all changes on analyst ratings page. See what analysts think about HUBS stock.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Oppenheimer analyst Jason Helfstein downgraded Trade Desk Inc (NASDAQ:TTD) from Outperform to Perform. Trade Desk shares closed at $23.49 on Thursday. See how other analysts view this stock.
- B of A Securities analyst Matt Bullock downgraded HubSpot Inc (NYSE:HUBS) from Buy to Underperform and lowers the price target from $300 to $180. HubSpot shares closed at $243.72 on Thursday. See how other analysts view this stock.
- Stifel analyst Matthew Smith downgraded Vital Farms, Inc. (NASDAQ:VITL) from Buy to Hold and cut the price target from $34 to $10. Vital Farms shares closed at $9.52 on Thursday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Raghuram Selvaraju downgraded Entrada Therapeutics (NASDAQ:TRDA) from Buy to Neutral. Entrada Therapeutics shares closed at $6.85 on Thursday. See how other analysts view this stock.
- Needham analyst Serge Belanger downgraded Amphastar Pharmaceuticals, Inc (NASDAQ:AMPH) from Buy to Hold. Amphastar Pharma shares closed at $24.03 on Thursday. See how other analysts view this stock.
Considering buying HUBS stock? Here’s what analysts think:
Photo via Shutterstock